Preface
Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma
Translational Andrology and Urology
2016;
5
(5)
:633-635
.
(18 October 2016)
Review Article
Why are upper tract urothelial carcinoma two different diseases?
Translational Andrology and Urology
2016;
5
(5)
:636-647
.
(18 October 2016)
Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
Translational Andrology and Urology
2016;
5
(5)
:648-654
.
(18 October 2016)
Genetics and biological markers in urachal cancer
Translational Andrology and Urology
2016;
5
(5)
:655-661
.
(18 October 2016)
Immunotherapy in urothelial carcinoma: fade or future standard?
Translational Andrology and Urology
2016;
5
(5)
:662-667
.
(18 October 2016)
Female with bladder cancer: what and why is there a difference?
Translational Andrology and Urology
2016;
5
(5)
:668-682
.
(18 October 2016)
How to optimally manage elderly bladder cancer patients?
Translational Andrology and Urology
2016;
5
(5)
:683-691
.
(18 October 2016)
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
Translational Andrology and Urology
2016;
5
(5)
:692-701
.
(18 October 2016)
Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
Translational Andrology and Urology
2016;
5
(5)
:702-710
.
(18 October 2016)
Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma
Translational Andrology and Urology
2016;
5
(5)
:711-719
.
(18 October 2016)
Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature
Translational Andrology and Urology
2016;
5
(5)
:720-734
.
(18 October 2016)
Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
Translational Andrology and Urology
2016;
5
(5)
:735-744
.
(18 October 2016)
Editorial
Building bridges in urothelial carcinoma to face common challenges
Translational Andrology and Urology
2016;
5
(5)
:745-748
.
(18 October 2016)
Original Article
Analysis of semen parameters during 2 weeks of daily ejaculation: a first in humans study
Translational Andrology and Urology
2016;
5
(5)
:749-755
.
(18 October 2016)
The impact of androgen deprivation on artificial urinary sphincter outcomes
Translational Andrology and Urology
2016;
5
(5)
:756-761
.
(18 October 2016)
Urethral catheters and medical malpractice: a legal database review from 1965 to 2015
Translational Andrology and Urology
2016;
5
(5)
:762-773
.
(18 October 2016)
Emphysematous pyelonephritis: the impact of urolithiasis on disease severity
Translational Andrology and Urology
2016;
5
(5)
:774-779
.
(18 October 2016)
Laparoscopic adrenalectomy for pheochromocytoma-does size matter? A single surgeon comparative study
Translational Andrology and Urology
2016;
5
(5)
:780-783
.
(18 October 2016)
Are antibiotics necessary during routine cystoscopic stent removal?
Translational Andrology and Urology
2016;
5
(5)
:784-788
.
(18 October 2016)
Educational program on sexual medicine for medical students: pilot project in Brazil
Translational Andrology and Urology
2016;
5
(5)
:789-793
.
(18 October 2016)
Review Article
Malignancy in disorders of sex development
Translational Andrology and Urology
2016;
5
(5)
:794-798
.
(18 October 2016)
Editorial
Results from the reduce trial on the effect of prostate size on incident lower urinary tract symptoms in men with mild to no current symptoms: do they justify prophylactic intervention?
Translational Andrology and Urology
2016;
5
(5)
:799-800
.
(18 October 2016)
Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma
Translational Andrology and Urology
2016;
5
(5)
:801-803
.
(18 October 2016)
Meet the Professor
Dr. Arthur L. Burnett: surgical treatment for penile cancer
Translational Andrology and Urology
2016;
5
(5)
:804-805
.
(18 October 2016)
Dr. Bang-Ping Jiann: PDE5 inhibitors in erectile dysfunction
Translational Andrology and Urology
2016;
5
(5)
:806-807
.
(18 October 2016)
Prof. Arthur Sagalowsky: cytoreductive nephrectomy is still important for advanced/metastatic renal cell cancer but many still need to be proved
Translational Andrology and Urology
2016;
5
(5)
:808-809
.
(18 October 2016)
Prof. Mitchell Humphreys: a pioneer in the natural orifice translumenal endoscopic surgery (NOTES)
Translational Andrology and Urology
2016;
5
(5)
:810-811
.
(18 October 2016)
Disclosure:
The focused issue “Urothelial Carcinoma” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Shahrokh F. Shariat and Romain Mathieu served as the unpaid Guest Editors for the focused issue.
